CoChat

Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission

Open access
Sebban, C, Zhang, X Q, Tesolin‐Decros, B, Millan, M J, Spedding, M · 1999 · British Journal of Pharmacology
Cited by 81

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

The electroencephalographic (EEG) effects of drugs interacting with dopaminergic and noradrenergic systems were studied in conscious rats. Power spectra (0–30 Hz) were recorded from electrodes implanted bilaterally in the prefrontal cortex. Drug effects on EEG power were calculated as the spectral power following drug administration divided by the spectral power after vehicle administration. Dopaminergic agonists at low doses, (apomorphine 0.01 mg kg−1 s.c., quinpirole 0.01 mg kg−1 i.p.) and dopaminergic antagonists (haloperidol 1 mg kg−1 i.p., raclopride 2.5 mg kg−1 s.c.), which decrease dopaminergic transmission, induced an increase of EEG power. Conversely, dopaminergic agonists at higher doses (apomorphine 0.5 mg kg−1 s.c., quinpirole 0.5 mg kg−1 i.p.) which increase activation of postsynaptic D 2 and D 3 receptors, induced a decrease of EEG power. The α 1‐adrenoceptor antagonists (phenoxybenzamine 0.64 mg kg−1 s.c., prazosin 0.32 mg kg−1 s.c.) and the α 2‐adrenoceptor agonists (UK 14304 0.05 mg kg−1 s.c., clonidine 0.025 mg kg−1 i.p.), which decrease noradrenergic transmission, induced an increase of EEG power. Conversely, the α 1‐adrenoceptor agonist, cirazoline (0.05 mg kg−1 s.c.), the adrenergic agent modafinil (250, 350 mg kg−1 i.p.) and α 2‐adrenoceptor antagonists (RX 821002 0.01 mg kg−1 s.c., yohimbine 0.5 mg kg−1 i.p.), which increase noradrenergic transmission, induced a decrease of EEG power. The effects of prazosin (0.64 mg kg−1 s.c.) were dose‐dependently antagonized by co‐administration with modafinil and cirazoline, but not by apomorphine. In conclusion, pharmacological modulation of dopaminergic and noradrenergic transmission may result in consistent EEG changes: decreased dopaminergic or noradrenergic activity induces an increase of EEG spectral power; while increased dopaminergic or noradrenergic activity decreases EEG spectral power. British Journal of Pharmacology (1999) 128, 1045–1054; doi:10.1038/sj.bjp.0702894

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0702894

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 81

Metadata

Authors
Sebban, C., Zhang, X. Q., Tesolin‐Decros, B., Millan, M. J., & Spedding, M.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
1999-11
Volume
128
Issue
5
Pages
1045-1054
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2069218117
Cited by
81
References
2
FWCI
0.80
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.